Obesity
Commentary
Finding ‘bright lights’: Why family physician continues to love practicing mid-career
“Seeing opportunities to practice preventative medicine in family medicine made me realize the specialty was the perfect fit for me.”
Conference Coverage
Low-calorie ketogenic diet improves immune function
“Despite the strong weight loss it induces, it preserves muscle mass and function and improves resting metabolic rate.”
News
Tirzepatide (Mounjaro) approved for type 2 diabetes
Endocrinologists voice enthusiasm for the first approved agent for patients with type 2 diabetes that is a dual incretin agonist, but they also...
Conference Coverage
A surprise and a mystery: NAFLD in lean patients linked to CVD risk
The link between nonalcoholic fatty liver disease and higher risk of CVD may extend beyond people who are overweight or living with obesity.
From the Journals
NAFLD vs. MAFLD: What’s in a name?
NAFLD may not be the most appropriate name because “nonalcoholic” may overemphasize the absence of alcohol, but is “metabolic associated” any...
From the Journals
Screening for diabetes at normal BMIs could cut racial disparities
Diabetes screening for Asian and Black individuals aged 35 and over, even at BMIs that are not considered overweight, would be ‘a good place to...
From the Journals
Obesity interactions complex in acute pancreatitis
Severity scores based on body mass index alone do not accurately predict disease severity in patients with acute pancreatitis.
Conference Coverage
Vegan diet helps shed pounds but doesn’t dint diabetes
A vegan diet most likely led to weight loss because it is “associated with a reduced calorie intake due to a lower content of fat and higher...
Conference Coverage
Calorie counting and exercise ‘of limited value’ for obesity weight loss
“Our survey results indicate that, while the majority of adults with obesity are actively trying to reduce their weight, using a variety of...
Conference Coverage
New research holds promise for fighting obesity, says expert
A growing understanding of adipose tissue as an endocrine organ responsible for weight control opens avenues for treatment, she says.
Feature
Tirzepatide succeeds in obesity in SURMOUNT-1, says Lilly
The once-weekly investigational twincretin drug is in phase 3 development for obesity and under regulatory review, with a decision expected soon...